| (210) | Number of the EPO application | 21724012 |
| (220) | Filing date of the EPO application | 2021.04.23 |
| (80) | EPO patent specification publication (B) | EPB nr. 05/2024, 2024.01.31 |
| (110) | EPO patent number | 4138790 |
| (21) | Number of the application | e 2023 0230 |
| (71) | Name(s) of applicant(s), code of the country | Vicore Pharma AB, SE; |
| (72) | Name(s) of inventor(s), code of the country | CAMBER Ola, SE;
EVERAERT Arnout, BE;
GRUDÉN Stefan, SE; |
| (73) | Name(s) of owner(s), code of the country | Vicore Pharma AB, SE; |
| (54) | Title of the invention | NEW DRY POWDER COMPOSITION FOR PERORAL ADMINISTRATION |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/48 (2006.01.01); A61K 31/4178 (2006.01.01); A61K 47/02 (2006.01.01); A61K 47/10 (2017.01.01); A61P 11/00 (2006.01.01) |
| (19) | Country | SE |
| (41) | Date of publication of the application | 2023.03.31 |
| (30) | Priority | 202006079, 2020.04.24, GB |
| (86) | International application | PCT/GB2021/050994, 2021.04.23 |
| (87) | International publication | WO 2021/214488, 2021.10.28 |